Wołowiec, Łukasz, et al. “Modulation of Inflammation in Heart Failure: The Role of Ziltivekimab and Canakinumab”. Journal of Education, Health and Sport, vol. 65, Oct. 2024, p. 55579, doi:10.12775/JEHS.2024.65.55579.